Login to Your Account

FDA lays out a plan to step up PRD drug development

By Mari Serebrov
Washington Editor

Wednesday, July 9, 2014
Keeping up with its obligations under the FDA Safety and Innovation Act (FDASIA), the FDA issued its strategic plan for accelerating the development of drugs and medical devices to treat rare diseases in children. The plan, released Wednesday, outlines four agency objectives and promises a number of guidances on the subject.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription